About Sensus Healthcare
Sensus Healthcare is a publicly listed company based in Boca Raton (United States) founded in 2010. It operates as a non-invasive skin cancer treatments are developed and marketed. Sensus Healthcare has raised $12.24 million across 4 funding rounds. The company has 54 employees. Sensus Healthcare has completed 2 acquisitions, including Aesthetic Laser Partners and Aesthetic Mobile Laser Services. Sensus Healthcare offers products and services including SRT-100, SRT-100+, and SRT-100 Vision. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is SENSUS HEALTHCARE, INC. Its competitors include Koya Medical, Theragenics, Eckert & Ziegler BEBIG, Concure Oncology and C4 Imaging and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
Sensus Healthcare develops and markets products and services for non-invasive treatment of non-melanoma skin cancers. Products use Sensus proprietary mobile X-ray technology. Acquired Topex, a skin cancer radiotherapy treatment system developer, which had developed SRT-100. The device delivers superficial radiation therapy that penetrates only five millimeters below the skins surface to treat basal and squamous cell carcinoma. Product is FDA CE approved.
- Headquarters Boca Raton, United States
- Employees 54
- Stage Public
- SectorsHealthcare
- Website sensushealthcare.com
- Social LinkedIn X Facebook Instagram
- Legal Name Sensus Healthcare, Inc.
- Annual Revenue$27.48 M (USD)-34.26as on Dec 31, 2025
- Net Profit-$7.72 M (USD)-216.13as on Dec 31, 2025
- EBITDA-$9.68 M (USD)-213.6as on Dec 31, 2025
- Total Equity Funding$12.24M (USD)
in 4 rounds
- Latest Funding Round$2.2M (USD), Series A
Jan 2016
- Employee Count54
- Investments & AcquisitionsAesthetic Laser Partners
& 1 more
Products & Services of Sensus Healthcare
Sensus Healthcare offers a comprehensive portfolio of products and services, including SRT-100, SRT-100+, and SRT-100 Vision.
Provides non-invasive treatment for skin cancer and keloids without surgery.
Advanced system for effective non-melanoma skin cancer and keloid therapy.
Features ultrasound for precise, painless radiotherapy treatments.
Funding Insights of Sensus Healthcare
Sensus Healthcare has successfully raised a total of $12.24M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2.2 million completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.24M
- Total Rounds 4
- Last Round Series A — $2.2M
- First Round $6.26M
(Mar 2011)
All 4 funding rounds of Sensus Healthcare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2016 | $2.2M | Series A | – | – | – |
| Jan 2013 | $1.4M | Series A | – | – | – |
| Dec 2012 | $2.39M | Series A | – | – | – |
| Mar 2011 | $6.26M | Series A | – | – | – |
People of Sensus Healthcare
29 people are tracked at Sensus Healthcare (14 in leadership, 11 in board & advisors, 4 in team); the tracked headcount is 54.
| Name | Role | Group |
|---|---|---|
Javier Rampolla | CFO | Leadership |
Michael Sardano | President & Chief Commercial Officer | Leadership |
Madison Foti | Vice President Operations | Leadership |
Joseph C. Sardano | CEO | Leadership |
Maggie Martinez | Chief Operational Officer | Leadership |
Stephanie Tipton | VP of Marketing | Leadership |
Jeffrey Starling | VP of Sales | Leadership |
Monica DiGioia | VP of Clinical Affairs | Leadership |
Christopher Machuzak | VP of Sales | Leadership |
David Solomon | VP of Business Development | Leadership |
Troy Kirchhoefer | Vice President Of Sales | Leadership |
Dan Ladd | Medical Director, Center Of Excellence | Leadership |
John Decoursey | Director Clinical Applications | Leadership |
Rejo Raju | Director Of Engineering | Leadership |
Bill McCall | Director | Board & advisors |
Anthony B. Petrelli | Director | Board & advisors |
Megan Cornish | Director | Board & advisors |
Robert E. Beer | Medical Advisor | Board & advisors |
William I. Roth | Medical Advisor | Board & advisors |
Michael H. Gold | Medical Advisor | Board & advisors |
9 more people are available in the full profile.
Complete people profiles for Sensus Healthcare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Sensus Healthcare
Sensus Healthcare is a publicly listed company on the NASDAQ with ticker symbol SRTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Jun 2016
- Listed onNASDAQ: SRTS
- Listed entitySensus Healthcare, Inc.
- Exchange sectorHealth technology
- ISINUS81728J1097
- Share price$2.89 (-1.37% on the day) · 2026-10-13
- Market capitalisation$47.6M
- EPS (diluted, trailing year)$-0.94
- Volume (last session)18,411
Financials of Sensus Healthcare
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $27.5M | -$7.7M | -$9.7M |
| 2024 | $41.8M | $6.7M | $8.5M |
| 2023 | $24.4M | $485,000 | $30,000 |
| 2022 | $44.5M | $24.2M | $15.2M |
| 2021 | $27.0M | $4.1M | $4.7M |
Detailed financial statements for Sensus Healthcare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sensus Healthcare
Sensus Healthcare has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Aesthetic Laser Partners and Aesthetic Mobile Laser Services.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Rental services for aesthetic laser equipment are provided to clients. | aestheticlaserpartners.com | Altamonte Springs, United States | 1999 | Aug 2020 | •••• | |
Provider of clinical training and laser equipment rental services | aestheticmobilelaser.com | Deerfield Beach, United States | 1999 | Aug 2020 | •••• |
Complete acquisition details for Sensus Healthcare
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sensus Healthcare
6 dated milestones of Sensus Healthcare across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Sensus Healthcare is founded.
- Funding First funding round of $6.3M.
- Funding Latest funding round, Series A, of $2.2M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Aesthetic Laser Partners.
- Acquisition Acquires Aesthetic Mobile Laser Services.
Competitors of Sensus Healthcare
Sensus Healthcare has 7 listed competitors in our database, 6 of them funded. They include Koya Medical, Theragenics, Eckert & Ziegler BEBIG, Concure Oncology and C4 Imaging, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| koyamedical.com | 2018 | Oakland, United States | $37.02M | 122 | Provider of smart wearable compression technology for lymphedema and venous diseases | |
| theragenics.com | 1981 | Buford, United States | $9.44M | 566 | Manufacturer of surgical products and brachytherapy devices | |
| bebig.com | 1997 | Seneffe, Belgium | – | – | Brachytherapy devices are developed for prostate, breast, and gynecological cancers. | |
| breastmicroseed.com | 2014 | Mercer Island, United States | $14.04M | – | Breast microseed radiotherapy for early-stage breast cancer is developed. | |
| c4imaging.com | 2009 | Bellaire, United States | $7.35M | – | Image-guided procedures for prostate cancer treatment are provided. | |
| civatechoncology.com | 2006 | Durham, United States | $12.4M | – | Polymer-based devices for low-dose brachytherapy in solid tumors are provided. | |
| radiogel.com | 2006 | Richland, United States | $725,000 | – | Yttrium-90 brachytherapy devices for cancer treatment are developed. |
Detailed competitors of Sensus Healthcare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sensus Healthcare
The website of Sensus Healthcare (sensushealthcare.com) receives about 8.7K visits a month.
- Monthly visits8.7K
▲ 93.9% vs previous month
Websites whose visitors overlap most with Sensus Healthcare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
thedermcenters.com | thedermcenters.com | 100% | – | – | – |
infoforyourhealth.com | infoforyourhealth.com | 98% | – | – | – |
| elekta.com | 97% | 117.9K | #303,597 | View details | |
blacksalveinfo.com | blacksalveinfo.com | 62% | – | – | – |
topicalinfo.org | topicalinfo.org | 62% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Sensus Healthcare
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Oncology
10 companies that operate in the same segment as Sensus Healthcare (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sensus Healthcare
Complete news archive for Sensus Healthcare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sensus Healthcare
Sensus Healthcare was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Sensus Healthcare is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Sensus Healthcare is a funded company, having raised a total of $12.24M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6.26M, raised on Mar 2011.
Sensus Healthcare has 54 employees.
Annual revenue of Sensus Healthcare is $27.48M as on Dec 31, 2025.
Sensus Healthcare develops and markets products and services for non-invasive treatment of non-melanoma skin cancers. Products use Sensus proprietary mobile X-ray technology. Acquired Topex, a skin cancer radiotherapy treatment system developer, which had developed SRT-100. The device delivers superficial radiation therapy that penetrates only five millimeters below the skins surface to treat basal and squamous cell carcinoma. Product is FDA CE approved.
Sensus Healthcare's top competitors include Koya Medical, RadioGel and Theragenics.
Sensus Healthcare offers SRT-100, SRT-100+, and SRT-100 Vision.
Yes, Sensus Healthcare is publicly traded on NASDAQ under the ticker symbol SRTS.
Sensus Healthcare has made 2 acquisitions, including Aesthetic Laser Partners, and Aesthetic Mobile Laser Services.
Sensus Healthcare operates through Sensus Healthcare, Inc..